84-2806-53 [取扱停止]Glycogen Synthase Kinase 3 alpha, CT (GSK 3 alpha, GSK3alpha, GSK-3 alpha, GSK 3A, GSK3a, DKFZp686D0638) (MaxLight 490) 100ul G8170-42M-ML490

※お見積書はカートで印刷できます

冷蔵

特徴

  • MaxLight™490 is a new Blue-Green photostable dye conjugate comparable to DyLight™488, Alexa Fluor™488 and offers better labeling efficiency, brighter imaging and increased immunodetection.
  • Absorbance (491nm); Emission (515nm); Extinction Coefficient 73,000.
  • Glycogen synthase kinase 3-alpha (GSK3A)is a multifunctional protein serine kinase implicated in the control of several regulatory proteins including glycogen synthase and transcription factors.
  • It also plays a role in the WNT and PI3K signaling pathways.
  • Under resting conditions GSK3A and its homologs are highly phosphorylated at tyr279 in the phosphorylation loop.
  • Constitutive phosphorylation of this tyrosine is important for kinase activity.
  • Dephosphorylation of tyr279 after mitogen activation is accompanied by kinase inactivation.
  • PKA as well as PI3K-activated PKB inactivate GSK3A by phosphorylation at ser21 Lysophosphatidic acid primarily utilizes a PKC-dependent pathway to modulate GSK3 and certain growth factors (e.g., PDGFB), which control GSK3 mainly through PIK3-PKB, are able to regulate GSK3 through an alternative, redundant phospholipase-C-gamma-PKC pathway.4 Alzheimer disease (AD) is associated with increased production and aggregation of amyloid-beta-40 and -42 peptides into plaques.
  • GSK3A is required for maximal production of the beta-amyloid-40 and -42 peptides generated from the amyloid precursor protein (APP) by presenilin (PSEN1)-dependent gamma-secretase cleavage.
  • In vitro, lithium, a GSK3A inhibitor, blocked the production of the beta-amyloid peptides by interfering with the gamma-secretase step.
  • In mice expressing familial AD-associated mutations in APP and PSEN1, lithium reduced the levels of beta-amyloid peptides GSK3A also phosphorylates the tau protein (MAPT), the principal component of neurofibrillary tangles in AD, and suggested that inhibition of GSK3A may offer a new therapeutic approach to AD.
  • Applications:Suitable for use in FLISA, Western Blot, and Immunohistochemistry.
  • Other applications not tested.
  • Recommended Dilution:FLISA: 1:1,000Western Blot: 1:100-1:500Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Store product at 4°C in the dark.
  • DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Caution: MaxLight™490 conjugates are sensitive to light.
  • For maximum recovery of product, centrifuge the original vial prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein G affinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™490.
  • Specificity:Recognizes human GSK3A.
  • Isotype:IgG
  • Calc Applications Abbrev:FLISA IHC WB
  • Calc Crossreactivity:Hu
  • Immunogen:KLH-conjugated synthetic peptide located somewhere within aa 448-478 in the C-terminal region of human GSK3 alpha.
  • Shelf Life:1year
  • Swiss Prot Number:P49840
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2806-53
型番
G8170-42M-ML490
入り数
1個
標準価格
226,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る